Heart abnormalities in vascular endothelial growth factor b (vegf-b) deficient animals and methods relating to these heart abnormalities
CA 2363488 A1 · Owner: Eriksson, Ulf · Inventors: Eriksson, Ulf; Thoren, Peter; Aase, Karin
Overview
Its claims, description and drawings are in the Canadian Patents Database.
Open the CIPO recordAbstract From the Canadian patent
VEGF-B deficient animals show heart abnormalities that appear to be caused by atrioventricular (AV) conduction defects and ischemia of the myocardium. Methods are provided for screening a compound for atrioventricular conduction or ischemia modulating activity using a VEGF-B deficient non-human animal for , the treatment or alleviation of atrioventricular conduction defects or ischemia and for diagnosing heart diseases.
Read the whole patent
Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.
Why it's free to use
- Filed March 3, 2000. No grant is recorded for it in Canada; had it been granted, its 20-year term would have ended March 3, 2020.
- A certificate of supplementary protection adds at most two years for a drug, so even that would have ended by March 3, 2022.
- We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
Timeline
Timeline From CIPO dates
Sources & verification
Official CIPO records
Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.